Please login to the form below

Not currently logged in
Email:
Password:

AcelRx

This page shows the latest AcelRx news and features for those working in and with pharma, biotech and healthcare.

AcelRX’s potent opioid tablets set to win FDA backing for pain relief

AcelRX’s potent opioid tablets set to win FDA backing for pain relief

Panel voted 10 to 3 in favour of the treatment. An FDA advisory committee gave the nod to AcelRX’s potent opioid drug Dsuvia on Friday, recommending it should be approved ... Pamela Palmer, Co-Founder and Chief Medical Officer of AcelRx. If approved,

Latest news

  • Grunenthal and AcelRx’s Zalviso approved in EU Grunenthal and AcelRx’s Zalviso approved in EU

    Howie Rosen, interim CEO of AcelRx, said: “This is a significant event for AcelRx. ... delivery. AcelRx developed Zalviso and entered into a commercial collaboration with Grunenthal at the end of 2013.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals in September 2015 Pharma deals in September 2015

    PDL BioPharma is buying out the majority of the expected royalty stream from EU sales of AcelRX's phase III product, Zalviso for $65m. ... Royalty monetisation. 110. AcelRx Pharmaceuticals. PDL BioPharma. Zalviso sub-lingual formulation of sufentanil.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Raffi Asadorian joins AcelRx Pharmaceuticals Raffi Asadorian joins AcelRx Pharmaceuticals

    Speciality pharmaceutical company AcelRx Pharmaceuticals has appointed Raffi Asadorian as its new chief financial officer. ... Vince Angotti, chief executive officer at AcelRx, said: “I am thrilled to have Raffi join our team.

  • Dr Stephen Hoffman joins Bicycle Therapeutics Dr Stephen Hoffman joins Bicycle Therapeutics

    He is also a member of the board of directors of AcelRx Pharmaceuticals, Dicerna Pharmaceuticals and Genocea Biosciences.

  • Kala names Howard Rosen as chairman Kala names Howard Rosen as chairman

    Rosen has held several senior roles at major biotechs, including his current positions on the board of directors at AcelRX, Aldea, Entrega and PaxVax, where he is also chairman.

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics